International Health finalists

HeliMods proves that world-class aerospace innovation can thrive on the
Sunshine Coast.

HeliMods is an aerospace tech company that transforms how air-networks perform critical missions around the world. It collaborates with air operators and emergency service providers globally to deliver new technologies into aircraft for air ambulance, search and rescue, law enforcement and defence.

In the past year, HeliMods successfully delivered advanced mission systems that automate the patient loading process for one of the world’s largest air ambulance programs in British Columbia. This achievement enabled interoperability across helicopter, aircraft and road ambulance platforms.

Its top export markets are Canada and the US.

Visit HeliMods website.

Linear Clinical Research takes innovation from Western Australia to the world. The organisation partners with leading biotechnology and pharmaceutical companies to accelerate the development of innovative therapies. This helps to bring new treatments to patients faster.

Core services include trial design consultation, clinical operations, medical oversight, regulatory support, data management and patient care. These are all delivered through two purpose-built, state-of-the-art clinics in Perth.

Since inception in 2010, Linear has delivered more than 500 early-phase trials in collaboration with clients from more than 16 countries.

Its top export markets are China, the US, the UK, Denmark, Switzerland, South Korea and Taiwan.

Visit Linear Clinical Research website.

Tasmanian biotechnology company Marinova delivers highly bioactive seaweed extracts to the global health industry.

Its portfolio of branded marine ingredients are sought after by some of the world’s most trusted nutraceutical brands. Marinova also collaborates with leading global research institutions and pharmaceutical companies to produce pharmaceutical-grade compounds.

Marinova currently exports to 40 countries. In the past year, the company increased its sales to Greece by more than 860% through a strategic partnership with a Greek pharmaceutical company.

Its top export markets are the US, Taiwan, the UK, Greece, Malaysia and Italy.

Visit Marinova website.

Mayne Pharma is on a mission to offer patients everywhere better, safer and more accessible medicines.

The company focuses on commercialising novel pharmaceuticals. It helps local and international companies formulate, develop and commercialise new products and innovations for global markets.

A recent large investment in its South Australian facility has improved manufacturing and packaging capabilities. These enable Mayne Pharma to unlock a range of new opportunities and expand into previously inaccessible markets.

Its top export markets are Canada, the US, South Korea, Germany, Spain, Thailand, Switzerland, New Zealand, Sri Lanka and China.

Visit Mayne Pharma website.

Tooth cavities are the most common health condition worldwide, affecting 2 billion people.

SDI is a world leader in developing specialist tooth filling and tooth whitening dental materials to improve the clinical outcomes of smiles across the world.

SDI improves oral health by developing products that subscribe to the notion of minimal intervention dentistry. This new frontier focuses on prevention and patient comfort by reducing drills and treatment time.

SDI products are sold to dentists in over 100 countries.

Its top export markets are the US, the UK, France, Brazil, Spain, Canada, Germany, Poland, Saudi Arabia and South Korea.

Visit SDI website.

Southern Star Research is a full-service contract research organisation (CRO) supporting biotech, pharmaceutical and medical device companies. It simplifies and accelerates the clinical trial process, helping sponsors bring treatments to market faster.

Southern Star’s global network of experts deliver high-quality services to meet the unique needs of each study. Services span medical writing, clinical monitoring, project management, biostatistics, data management and quality assurance. Southern Star’s global reach allows it to support multi-regional trials with local expertise and in compliance with international standards. 

Its top export markets are the US, Switzerland, South Korea, Ireland, China, France, Singapore, Germany, Japan and New Zealand.

Visit Southern Star Research website.